RE:RE:Nothing like a bit of fear to promote PMN310 science Interesting how they first describe AD as "the woman’s hard-to-diagnose, preexisting condition" before later clarifying that "Like all Alzheimer’s patients, the woman was also at risk of a condition called cerebral amyloid angiopathy (CAA)" then mitigating it with "It takes sophisticated, expensive brain imaging to detect signs of CAA"
So I guess this is their defense strategy, and what a shame as things were going so great until there was a corpse available. Well maybe Pfizer can lend them some lobby help.